Issued Patents 2021
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11111232 | Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Catherine White, Abdelghani Achab, Indu T. Bharathan, Xavier Fradera, Yongxin Han +7 more | 2021-09-07 |
| 11096930 | Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase | Phillip M. Cowley, Meredeth A. McGowan, Thomas J. Brown, Yongxin Han, Qinglin Pu +3 more | 2021-08-24 |
| 11053243 | Inhibitors of hepatitis C virus replication | Craig A. Coburn, Steven W. Ludmerer, Hao Wu, Richard Soil, Bin Zhong +1 more | 2021-07-06 |
| 11034661 | Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors | Liangqin Guo, Yongxin Han, Shuwen He, Joseph A. Kozlowski, Ravi Nargund +6 more | 2021-06-15 |
| 10995085 | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Yongxin Han, Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau +8 more | 2021-05-04 |
| 10988487 | Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Abdelghani Achab, Purakkattle Biju, Timothy A. Cernak, Yongqi Deng, Xavier Fradera +10 more | 2021-04-27 |
| 10927086 | Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Dane Clausen, Liangqin Guo, Yongxin Han, Shuwen He, Joseph A. Kozlowski +4 more | 2021-02-23 |